Er-Kim to distribute Puma’s Nerlynx in Central Asian, Eastern European countries

The therapy is intended for treating adults with early-stage human epidermal growth factor receptor 2-positive breast cancer. Credit: Angiola Harry on Unsplash.



  • Er-Kim to distribute Puma’s Nerlynx in Central Asian, Eastern European countries